{
    "organizations": [],
    "uuid": "95046ac3538134653d0021846079ea47b9a4d4b8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-china-regenerative-medicine-intern/brief-china-regenerative-medicine-international-entered-agreement-with-shanghai-lingang-songjiang-high-tech-industry-development-idUSFWN1PB0CS",
    "ord_in_thread": 0,
    "title": "BRIEF-China Regenerative Medicine International Entered Agreement With Shanghai Lingang Songjiang High-Tech Industry Development",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - China Regenerative Medicine International Ltd:\n* ENTERED COOPERATION FRAMEWORK AGREEMENT WITH SHANGHAI LINGANG SONGJIANG HIGH-TECH INDUSTRY DEVELOPMENT\n* AGREEMENT FOR DEVELOPMENT & CONSTRUCTION OF SCIENCE OASIS SITEâ€‹ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-16T17:25:00.000+02:00",
    "crawled": "2018-01-17T19:44:41.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "china",
        "regenerative",
        "medicine",
        "international",
        "ltd",
        "entered",
        "cooperation",
        "framework",
        "agreement",
        "shanghai",
        "lingang",
        "songjiang",
        "industry",
        "development",
        "agreement",
        "development",
        "construction",
        "science",
        "oasis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}